Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top
Clinical and Experimental Nephrology

Association between early proteinuria reduction and kidney outcomes in Japanese patients with IgA nephropathy: The Japan Chronic Kidney Disease Database

Published in:
Authors
Yuichiro Yano
Hajime Nagasu
Hiroshi Kanegae
Seiji Itano
Masaomi Nangaku
Hitoshi Suzuki
Mizuki Ohashi
Hirokazu Okada
Yusuke Suzuki
Naoki Kashihara
Published in
Clinical and Experimental Nephrology | Issue 3/2026

Abstract

Background

Proteinuria reduction is an established surrogate endpoint for IgA nephropathy (IgAN) progression in international trials, but evidence in Japanese populations is scarce. We aimed to assess the association between early changes in proteinuria and long-term kidney outcomes in a large, real-world cohort of Japanese patients with IgAN.

Methods

This nationwide, multicenter cohort study utilized the Japan Chronic Kidney Disease Database (J-CKD-DB) data. We analyzed 1,039 IgAN patients (mean age 48.8 years; 46.0% women), categorized by dipstick proteinuria change at 9 ± 1 months from baseline: a reduction group (≥1-step improvement) and a non-reduction group (stable or worsened). The primary outcome was total eGFR slope; secondary was a composite kidney event (≥40% eGFR decline or eGFR < 15 mL/min/1.73 m2).

Results

: The mean baseline eGFR was 56.8 (±27.7) mL/min/1.73 m2. During a median follow-up of 1,357 days, the mean annual eGFR slope in the reduction group was -0.13 mL/min/1.73 m2 (95% CI, -0.37 to 0.11), compared to -2.73 mL/min/1.73 m2 (95% CI, -2.96 to -2.49) in the non-reduction group. In multivariable adjustment for baseline covariates, the hazard ratio for the composite kidney event in the reduction group was significantly lower compared to the non-reduction group was 0.79 (95% CI, 0.63–0.99).

Conclusions

In this large, real-world Japanese cohort, early dipstick proteinuria reduction was significantly associated with both a slower long-term eGFR decline and a lower risk of major kidney events. These findings may support the use of early proteinuria reduction as a surrogate endpoint for clinical trials and regulatory evaluation of IgA nephropathy in Japan.
Title
Association between early proteinuria reduction and kidney outcomes in Japanese patients with IgA nephropathy: The Japan Chronic Kidney Disease Database
Authors
Yuichiro Yano
Hajime Nagasu
Hiroshi Kanegae
Seiji Itano
Masaomi Nangaku
Hitoshi Suzuki
Mizuki Ohashi
Hirokazu Okada
Yusuke Suzuki
Naoki Kashihara
Publication date
23-01-2026
Publisher
Springer Nature Singapore
Published in
Clinical and Experimental Nephrology / Issue 3/2026
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-025-02799-1
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Other articles of this Issue 3/2026

Outcomes of tyrosine kinase inhibitor monotherapy for advanced renal cell carcinoma arising in patients with kidney transplantation: comparison with sporadic and end-stage renal disease populations

Serum zinc-α2-glycoprotein and renal dysfunction in the general population: evidence from a 13-year cohort study

Effects of dialysis therapies on circulating levels of endothelial markers after kidney transplant in children: focus on positive aspect of peritoneal dialysis

Novel clinical application of urinary angiotensin-converting enzyme assay in renal sarcoidosis: a retrospective observational study

Amino acid metabolism in diabetic kidney disease

  • Review article

Differential urinary IgG fragmentation in diabetes and IgA nephropathy

SPONSORED

Adherence to injectables

In this podcast, Professor Jorge Sánchez shares his insights into identifying and addressing poor adherence to injectable therapy, offering guidance that can help to support patients with chronic diseases through their treatment journey.

Sponsor:
  • Novartis Pharma AG
Prof. Jorge Sánchez
Listen now
Podcast

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Adis Journal Podcast/© Adis, Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images